These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9403359)

  • 41. Canine external carotid vasoconstriction induced by 2-(2-aminoethyl)quinoline (D-1997), a novel agonist at vascular 5-HT1-like receptors.
    Terrón JA; Hoyo-Vadillo C; López-Muñoz FJ; Villalón CM
    Proc West Pharmacol Soc; 1994; 37():93-4. PubMed ID: 7984686
    [No Abstract]   [Full Text] [Related]  

  • 42. Rational treatment of migraine.
    Weber RB
    South Med J; 1972 Jun; 65(6):737-40. PubMed ID: 5032378
    [No Abstract]   [Full Text] [Related]  

  • 43. The pathophysiology of migraine: a tentative synthesis.
    Lance JW
    Pathol Biol (Paris); 1992 Apr; 40(4):355-60. PubMed ID: 1379708
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonin receptor subtypes and neuropsychiatric diseases: focus on 5-HT1D and 5-HT3 receptor agents.
    Peroutka SJ
    Pharmacol Rev; 1991 Dec; 43(4):579-86. PubMed ID: 1663621
    [No Abstract]   [Full Text] [Related]  

  • 45. 5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy.
    Deliganis AV; Peroutka SJ
    Headache; 1991 Apr; 31(4):228-31. PubMed ID: 1646776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison between venoconstrictor effects of sumatriptan and ergotamine in migraine patients.
    Panconesi A; Anselmi B; Curradi C; Perfetto F; Piluso A; Franchi G
    Headache; 1994 Apr; 34(4):194-7. PubMed ID: 8014033
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of some biogenic substances in migraine and relevant mechanism in antimigraine action of ergotamine--studies in an experimental model for migraine.
    Saxena PR; de Vlaam-Schluter GM
    Headache; 1974 Jan; 13(4):142-63. PubMed ID: 4149297
    [No Abstract]   [Full Text] [Related]  

  • 48. [Migraine].
    Martínez Lage JM; Rodríguez y MC; Vázquez C
    Neurologia; 1996 Jan; 11(1):20-31. PubMed ID: 8714172
    [No Abstract]   [Full Text] [Related]  

  • 49. [Greater value of sumatriptan over ergot alkaloids still not proven].
    van Luijn JC
    Ned Tijdschr Geneeskd; 1993 Dec; 137(49):2554-8. PubMed ID: 8272145
    [No Abstract]   [Full Text] [Related]  

  • 50. Agonists and antagonists of 5-hydroxytryptamine on venomotor receptors.
    Aellig WH
    Adv Neurol; 1982; 33():321-4. PubMed ID: 7055012
    [No Abstract]   [Full Text] [Related]  

  • 51. [Mechanism of action of drugs currently used in the prevention of migraine].
    Fanchamps A
    Minerva Med; 1976 Jun; 67(28):1858-60. PubMed ID: 59325
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic windows.
    Mol Interv; 2010 Apr; 10(2):69-71. PubMed ID: 20368365
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of 5-hydroxytryptamine and ergotamine on human superficial temporal artery.
    Ostergaard JR; Mikkelsen E; Voldby B
    Cephalalgia; 1981 Dec; 1(4):223-8. PubMed ID: 7347625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The association of the combination of sumatriptan and methysergide in myocardial infarction in a premenopausal woman.
    Liston H; Bennett L; Usher B; Nappi J
    Arch Intern Med; 1999 Mar; 159(5):511-3. PubMed ID: 10074961
    [TBL] [Abstract][Full Text] [Related]  

  • 55. History lessons. This incident underscored the importance of a fundamental nursing activity: history-taking.
    Lilley LL; Guanci R
    Am J Nurs; 1997 Apr; 97(4):12, 14. PubMed ID: 9103916
    [No Abstract]   [Full Text] [Related]  

  • 56. Mechanism of the effect of 5-HT antagonists (antiserotonins) in migraine.
    Grossmann V
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1968; 11(5):749-56. PubMed ID: 5257745
    [No Abstract]   [Full Text] [Related]  

  • 57. Propranolol in the treatment of migraine.
    Behan PO; Reid M
    Practitioner; 1980 Feb; 224(1340):201-3. PubMed ID: 6988825
    [No Abstract]   [Full Text] [Related]  

  • 58. Basic mechanisms of antimigraine drugs.
    Fozard JR
    Adv Neurol; 1982; 33():295-307. PubMed ID: 7034488
    [No Abstract]   [Full Text] [Related]  

  • 59. The treatment of acute migraine.
    Olesen J
    Rev Neurol (Paris); 2005 Jul; 161(6-7):679-80. PubMed ID: 16141957
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of antimigraine drugs on retinal spreading depression.
    Wiedemann M; de Lima VM; Hanke W
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):552-6. PubMed ID: 8740149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.